These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11108661)

  • 1. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes.
    Li JJ; Cao Y; Young MR; Colburn NH
    Mol Carcinog; 2000 Nov; 29(3):159-69. PubMed ID: 11108661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
    Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
    Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
    Cooper S; Ranger-Moore J; Bowden TG
    Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
    Matthews CP; Birkholz AM; Baker AR; Perella CM; Beck GR; Young MR; Colburn NH
    Cancer Res; 2007 Mar; 67(6):2430-8. PubMed ID: 17363560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.
    Young MR; Li JJ; Rincón M; Flavell RA; Sathyanarayana BK; Hunziker R; Colburn N
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9827-32. PubMed ID: 10449779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
    Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
    Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual activity of pyrrolidine dithiocarbamate on kappaB-dependent gene expression in U937 cells: II. Regulation by tumour necrosis factor-alpha.
    Watanabe K; Kazakova I; Furniss M; Miller SC
    Cell Signal; 1999 May; 11(5):371-83. PubMed ID: 10376811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathway.
    Zuo Z; Cai T; Li J; Zhang D; Yu Y; Huang C
    Environ Health Perspect; 2012 Apr; 120(4):547-53. PubMed ID: 22472290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation.
    Han B; Rorke EA; Adhikary G; Chew YC; Xu W; Eckert RL
    PLoS One; 2012; 7(5):e36941. PubMed ID: 22649503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ; Westergaard C; Ghosh P; Colburn NH
    Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.
    Maślikowski BM; Wang L; Wu Y; Fielding B; Bédard PA
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.
    Tichelaar JW; Yan Y; Tan Q; Wang Y; Estensen RD; Young MR; Colburn NH; Yin H; Goodin C; Anderson MW; You M
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1148-56. PubMed ID: 20716630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
    Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
    Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
    Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members.
    Ma S; Rao L; Freedberg IM; Blumenberg M
    Gene Expr; 1997; 6(6):361-70. PubMed ID: 9495317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cFos is critical for MCF-7 breast cancer cell growth.
    Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
    Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.